Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling

Koyasu, 2003, The role of PI3K in immune cells, Nat Immunol, 4, 313, 10.1038/ni0403-313 Okkenhaug, 2003, PI3K in lymphocyte development, differentiation and activation, Nat Rev Immunol, 3, 317, 10.1038/nri1056 Deane JA, Fruman DA: Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu Rev Immunol 2004, in press. Ohashi, 2002, T-cell signalling and autoimmunity: molecular mechanisms of disease, Nat Rev Immunol, 2, 427, 10.1038/nri822 Kishimoto, 2003, Physiological functions of pten in mouse tissues, Cell Struct Funct, 28, 11, 10.1247/csf.28.11 Vanhaesebroeck, 2001, Synthesis and function of 3-phosphorylated inositol lipids, Annu Rev Biochem, 70, 535, 10.1146/annurev.biochem.70.1.535 Donahue, 2004, PI3K signaling controls cell fate at many points in B lymphocyte development and activation, Semin Cell Dev Biol, 15, 183, 10.1016/j.semcdb.2003.12.024 Fruman, 2000, Xid-like phenotypes: a B cell signalosome takes shape, Immunity, 13, 1, 10.1016/S1074-7613(00)00002-9 Fluckiger, 1998, Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation, EMBO J, 17, 1973, 10.1093/emboj/17.7.1973 Scharenberg, 1998, Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals, EMBO J, 17, 1961, 10.1093/emboj/17.7.1961 Khan, 1995, Defective B cell development and function in Btk-deficient mice, Immunity, 3, 283, 10.1016/1074-7613(95)90114-0 Satterthwaite, 1998, Btk function in B cell development and response, Semin Immunol, 10, 309, 10.1006/smim.1998.0123 Clayton, 2002, A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation, J Exp Med, 196, 753, 10.1084/jem.20020805 Jou, 2002, Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex, Mol Cell Biol, 22, 8580, 10.1128/MCB.22.24.8580-8591.2002 Suzuki, 2003, PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction, Nat Immunol, 4, 280, 10.1038/ni890 Saito, 2003, BTK regulates PtdIns-4,5-P2 synthesis important for calcium signaling and PI3K activity, Immunity, 19, 669, 10.1016/S1074-7613(03)00297-8 Leitges, 1996, Immunodeficiency in protein kinase cbeta-deficient mice, Science, 273, 788, 10.1126/science.273.5276.788 Glassford, 2003, BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells, Oncogene, 22, 2248, 10.1038/sj.onc.1206425 Forssell, 1999, Bruton’s tyrosine-kinase-deficient murine B lymphocytes fail to enter S phase when stimulated with anti-immunoglobulin plus interleukin-4, Scand J Immunol, 49, 155, 10.1046/j.1365-3083.1999.00483.x Saijo, 2002, Protein kinase C beta controls nuclear factor kappaB activation in B cells through selective regulation of the IkappaB kinase alpha, J Exp Med, 195, 1647, 10.1084/jem.20020408 Su, 2002, PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling, Nat Immunol, 3, 780, 10.1038/ni823 Grumont, 2002, B cell growth is controlled by phosphatidylinosotol 3-kinase-dependent induction of Rel/NF-kappaB regulated c-myc transcription, Mol Cell, 10, 1283, 10.1016/S1097-2765(02)00779-7 Solvason, 1998, Transgene expression of bcl-xL permits anti-immunoglobulin (Ig)-induced proliferation in xid B cells, J Exp Med, 187, 1081, 10.1084/jem.187.7.1081 Harriague, 2002, Imaging antigen-induced PI3K activation in T cells, Nat Immunol, 3, 1090, 10.1038/ni847 Schaeffer, 2000, Tec family kinases in lymphocyte signaling and function, Curr Opin Immunol, 12, 282, 10.1016/S0952-7915(00)00088-1 Labno, 2003, Itk functions to control actin polymerization at the immune synapse through localized activation of Cdc42 and WASP, Curr Biol, 13, 1619, 10.1016/j.cub.2003.08.005 Grasis, 2003, Inducible T cell tyrosine kinase regulates actin-dependent cytoskeletal events induced by the T cell antigen receptor, J Immunol, 170, 3971, 10.4049/jimmunol.170.8.3971 Schwartzberg, 2003, Amplifying Btk’s signal, Immunity, 19, 634, 10.1016/S1074-7613(03)00304-2 Cantrell, 2002, Protein kinase B (Akt) regulation and function in T lymphocytes, Semin Immunol, 14, 19, 10.1006/smim.2001.0338 Vivanco, 2002, The phosphatidylinositol 3-Kinase AKT pathway in human cancer, Nat Rev Cancer, 2, 489, 10.1038/nrc839 Otero, 2001, Cd19-dependent activation of Akt kinase in B-lymphocytes, J Biol Chem, 276, 1474, 10.1074/jbc.M003918200 Jones, 2000, Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo, J Exp Med, 191, 1721, 10.1084/jem.191.10.1721 Parsons, 2001, Expression of active protein kinase B in T cells perturbs both T and B cell homeostasis and promotes inflammation, J Immunol, 167, 42, 10.4049/jimmunol.167.1.42 Rathmell, 2003, Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of autoimmunity and lymphoma, Eur J Immunol, 33, 2223, 10.1002/eji.200324048 Kane, 2001, Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines, Nat Immunol, 2, 37, 10.1038/83144 Kane, 2003, The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3, Immunol Rev, 192, 7, 10.1034/j.1600-065X.2003.00008.x Ohteki, 2000, Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3, J Exp Med, 192, 99, 10.1084/jem.192.1.99 Wu, 2001, ‘Decisions, decisions.’: beta-catenin-mediated activation of TCF-1 and Lef-1 influences the fate of developing T cells, Nat Immunol, 2, 823, 10.1038/ni0901-823 Xu, 2003, Deletion of beta-catenin impairs T cell development, Nat Immunol, 4, 1177, 10.1038/ni1008 Burgering, 2002, Cell cycle and death control: long live Forkheads, Trends Biochem Sci, 27, 352, 10.1016/S0968-0004(02)02113-8 Stahl, 2002, The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2, J Immunol, 168, 5024, 10.4049/jimmunol.168.10.5024 Yusuf I, Zhu X, Kharas MG, Chen J, Fruman DA: Optimal B cell proliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcription factors. Blood 2004, in press. Raught, 2001, The target of rapamycin (TOR) proteins, Proc Natl Acad Sci USA, 98, 7037, 10.1073/pnas.121145898 Storz, 2002, 3′-phosphoinositide-dependent kinase-1 (PDK-1) in PI 3-kinase signaling, Front Biosci, 7, d886, 10.2741/storz Manning, 2003, Rheb fills a GAP between TSC and TOR, Trends Biochem Sci, 28, 573, 10.1016/j.tibs.2003.09.003 Kane, 2002, Akt-dependent phosphorylation specifically regulates Cot induction of NF-kappa B-dependent transcription, Mol Cell Biol, 22, 5962, 10.1128/MCB.22.16.5962-5974.2002 Yusuf, 2003, Regulation of quiescence in lymphocytes, Trends Immunol, 24, 380, 10.1016/S1471-4906(03)00141-8 Donahue, 2003, Proliferation and survival of activated B cells requires sustained antigen receptor engagement and phosphoinositide 3-kinase activation, J Immunol, 170, 5851, 10.4049/jimmunol.170.12.5851 Costello, 2002, Sustained and dynamic inositol lipid metabolism inside and outside the immunological synapse, Nat Immunol, 3, 1082, 10.1038/ni848 Frauwirth, 2002, The CD28 signaling pathway regulates glucose metabolism, Immunity, 16, 769, 10.1016/S1074-7613(02)00323-0 Niiro, 2003, Branches of the B cell antigen receptor pathway are directed by protein conduits Bam32 and Carma1, Immunity, 19, 637, 10.1016/S1074-7613(03)00303-0